A Phase I Safety and Pharmacokinetic Study of Gamitrinib Administered Intravenously to Patients With Advanced Cancer
Clinical trial NCT04827810 · RECRUITING
Trial details
- NCT number
- NCT04827810
- Sponsor
- Fox Chase Cancer Center
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-05
- Primary completion
- 2026-06-30
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.